Molecular biology studies have greatly enhanced our knowledge of thyroid tumorigenesis,
although their impact in clinical practice is still negligible. Most benign and malignant thyroid …

Como a maior parte dos carcinomas diferenciados tem um excelente prognóstico, alguns
autores têm considerado o tratamento convencional, isto é, a tiroidectomia total seguida de …

A number of molecular abnormalities have been described in association with the
progression from normal thyroid tissue to benign adenomas to well-differentiated and finally …

Thyroid cancer is the most common endocrine malignancy. Differentiated thyroid cancer
(DTC) with the two subtypes, papillary thyroid cancer (PTC) and follicular thyroid cancer …

Simple Summary The aim of this review is to provide a general overview about the
molecular markers (mutations and alterations) of thyroid cancers, present several molecular …

Therapeutic options for advanced, unresectable radioiodine-resistant thyroid cancers have
historically been limited. Recent progress in understanding the pathogenesis of the various …

Thyroid nodules represent heterogeneous tumors with distinct molecular signatures. While
benign thyroid nodules correspond to poly-or monoclonal tumors, thyroid carcinomas are …

Immunohistochemical techniques are pivotal tools for achieving a correct diagnosis in both
the histological and cytological fields and in predicting the clinical course of the disease …

Simple Summary Alterations to human proteins following their production can result in
changes to their function. In cancers specifically, these post-translational modifications …

Thyroid cancer is the most common malignancy in endocrine system, composed of four
major types; papillary thyroid carcinoma, follicular thyroid carcinoma, anaplastic thyroid …